Despite the data implicating the PI3K/AKT pathway as an important oncogenic driver pathway in T-ALL, in pediatric patients, there is currently little evidence to suggest that the PTEN genotype is a strong prognostic factor. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.